The Clinical Research of Mesylate Apatinib Combined With Docetaxel and S-1 as the First-line Treatment of Metastatic Gastric Cancer
The purpose of this study is to evaluate the efficacy and safety of Apatinib Mesylate Tablets combined with docetaxel and S-1 as the first-line treatment of metastatic gastric cancer.
100 项与 Tianmen Hospital of Traditional Chinese Medicine 相关的临床结果
0 项与 Tianmen Hospital of Traditional Chinese Medicine 相关的专利(医药)
100 项与 Tianmen Hospital of Traditional Chinese Medicine 相关的药物交易
100 项与 Tianmen Hospital of Traditional Chinese Medicine 相关的转化医学